Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement

This article was originally published in The Gray Sheet

Executive Summary

FDA’s device center launched the second round of its entrepreneurs-in-residence program, bringing in outside experts to the center to focus on streamlining data collection and the approval-to-reimbursement pathway.

Advertisement

Related Content

Hiring Plans Are Central To US FDA's Digital Health Plan
Bringing Private Payers To The Regulatory Table: FDA Reaches Out To Insurers
Ex-CMS Louis Jacques On Partnering With FDA And Keeping It Local
Louis Jacques On Coverage, Evidence And IDEs
Louis Jacques On Coverage, Evidence And IDEs
CDRH Accelerates Software Development To Improve Collaboration With Industry
FDA Unveils Plan To Strengthen Device Post-Market Surveillance
CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices
Calling All Innovators: FDA And CMS Seek Candidates For Parallel Review Pilot
Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program

Topics

Advertisement
UsernamePublicRestriction

Register

MT031659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel